Silver Book Fact

Visual impairment and blindness cause an annual health utility loss of approximately $10.5 billion. This figure measures lost quality of life when a disease has little or no short-term impact on mortality.

Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff. Economic Impact of Visual Impairment and Blindness in the United States. Archives of Ophthalmology. 2007; 125(4): 544-50. http://archopht.ama-assn.org/cgi/content/abstract/125/4/544

Reference

Title
Economic Impact of Visual Impairment and Blindness in the United States
Publication
Archives of Ophthalmology
Publication Date
2007
Authors
Frick, Kevin D., Emily W. Gower, John H. Kempen, and Jennifer L. Wolff
Volume & Issue
Volume 125, Issue 4
Pages
544-50
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Between 40% and 45% of all diabetics have some stage of diabetic retinopathy.  
  • From 2005 – 2008, around 4.2 million diabetics age 40 and older had diabetic retinopathy.  Of these, 655,000 had advanced diabetic retinopathy that could lead to severe vision loss.  
  • Nearly all patients with type 1 diabetes, and greater than 60% of patients with type 2, develop retinopathy within the first two decades of the disease.  
  • By 2020, the number of Americans age 40 and older who are blind or have low vision is projected to reach 5.5 million– growing from 3.3 million in 2004.  
  • The number of Medicare beneficiaries newly diagnosed with wet age-related macular degeneratino (AMD) more than doubled between 1994 and 2006.